• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about cannabigerol

Recent news which mentions cannabigerol

Avicanna Secures US Patent For Topical Cannabinoid Technology To Treat Pain And Inflammation
August 27, 2024
Tickers AVCNF NEWS
Tags News AVCNF Aras Azadian
From Benzinga
First-Ever Human Trial Finds CBG Reduces Anxiety And Boosts Memory
August 01, 2024
Tickers CBG NEWS
Tags anxiety medical cannabis Benzinga
From Benzinga
Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country
July 11, 2024
Tickers AVCN AVCNF CBD CBG
Tags News CBG Epidiolex
From Benzinga
Company Exploring CBG Production Signals New Era Of Commercial Success In Synthetic Biology
January 10, 2024
Tickers CANSF NEWS WLLW
Tags SUANFARMA cannabigerol Market News
From Benzinga
Willow Biosciences Announces Q2 2021 Results, Agrees To Supply Cellular Goods With CBG
August 09, 2021
Tickers CANSF
Tags second quarter earnings CANSF Cannabis
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap